Meanwhile, a study of Dhaka University’s Institute of Health Economics found that only 32 percent of Bangladeshis want to take the COVID-19 vaccine at the moment partially due to doubts over the vaccine’s effectiveness and concerns over side-effects.
Overall 84 percent people showed interest to take the vaccine at some stage – after a few weeks, months and years - but did not want to take the vaccine right now as they have doubt about efficacy, side-effect and some even believe the vaccines do not work, the study found.
Some 3,560 randomly selected people above 18 years were respondents of the study beginning January 10. The respondents were from 16 upazilas of eight districts in eight divisions and from Dhaka city area.
The vaccination is set to begin when Bangladesh’s Covid-19 fatalities rose to 8,055 with 14 more coronavirus-related deaths in 24 hours until Tuesday morning.
Bangladesh approved the emergency use of this vaccine on Jan 7. It inked a deal with the Serum Institute of India Pvt Ltd last month for procuring 30 million doses of the vaccine between January and June (five million doses each month).
The country received 2 million doses of vaccine as ‘gift’ from India last week.